204 related articles for article (PubMed ID: 5566873)
1. [Androgens in hematology].
Sanchez-Medal L
Minerva Med; 1971 Jun; 62(51):2598-604. PubMed ID: 5566873
[No Abstract] [Full Text] [Related]
2. [Therapy of hematologic diseases using androgens].
Sánchez-Medal L
Munch Med Wochenschr; 1971 Jun; 113(25):960-5. PubMed ID: 5108720
[No Abstract] [Full Text] [Related]
3. [Androgens in hematology].
Sanchez-Medal L
Cah Med; 1971 May; 12(7):515-22. PubMed ID: 5562270
[No Abstract] [Full Text] [Related]
4. [Corticotherapy in infantile hematology].
Paolucci G; Rosito P
Minerva Pediatr; 1969 Oct; 21(43):1989-2005. PubMed ID: 4326806
[No Abstract] [Full Text] [Related]
5. The hemopoietic action of androstanes.
Sanchez-Medal L
Prog Hematol; 1971; 7():111-36. PubMed ID: 4950580
[No Abstract] [Full Text] [Related]
6. Androgens and erythropoiesis.
Shahidi NT
N Engl J Med; 1973 Jul; 289(2):72-80. PubMed ID: 4575719
[No Abstract] [Full Text] [Related]
7. [Androstanes in clinical hematology].
Sánchez-Medal L
Rev Clin Esp; 1971 Mar; 120(6):535-8. PubMed ID: 5164711
[No Abstract] [Full Text] [Related]
8. [Do androgens have a therapeutic role in hematology?].
Delwiche F; Velu T
Rev Med Brux; 1985 Apr; 6(4):277-9. PubMed ID: 4039838
[No Abstract] [Full Text] [Related]
9. [Betamethasone phosphate in hematology].
Bauters F
Lille Med; 1971 Apr; 16():S 2:625-30. PubMed ID: 5293269
[No Abstract] [Full Text] [Related]
10. [Steroid therapy for hematologic diseases--indications and methods of administration].
Matsumoto N; Miwa S
Nihon Rinsho; 1979 Jun; 37(6):1302-7. PubMed ID: 384053
[No Abstract] [Full Text] [Related]
11. Hematologic effects of androgens revisited: an alternative therapy in various hematologic conditions.
Besa EC
Semin Hematol; 1994 Apr; 31(2):134-45. PubMed ID: 8066470
[No Abstract] [Full Text] [Related]
12. Use of androgens in hematologic disease.
Fried W
Postgrad Med; 1974 May; 55(5):155-61. PubMed ID: 4824723
[No Abstract] [Full Text] [Related]
13. [Androgen treatment of hematologic diseases].
Huang ZL
Zhonghua Nei Ke Za Zhi; 1990 Apr; 29(4):239-42. PubMed ID: 2226054
[No Abstract] [Full Text] [Related]
14. Physiologic mechanisms and the hematopoietic effects of the androstanes and their derivatives.
Gardner FH; Besa EC
Curr Top Hematol; 1983; 4():123-95. PubMed ID: 6352190
[No Abstract] [Full Text] [Related]
15. [Principles of treatment of hemoblastoses under ambulatory conditions].
Polonskaia EN; Vinogradova IuE; Lobanova NA; Iudina NI; Korovina VI
Ter Arkh; 1976; 48(8):54-60. PubMed ID: 828780
[No Abstract] [Full Text] [Related]
16. [Androgens in treatment of acquired bone marrow aplasia].
Jedrzejczak W
Wiad Lek; 1973 Mar; 26(6):535-9. PubMed ID: 4582004
[No Abstract] [Full Text] [Related]
17. [Clinical research on the antipyretic effects of indomethacin in systemic hemopathies].
Marcolongo R; Bianco G; Di Paolo N; Bravi A
Minerva Med; 1970 Oct; 61(82):4532-41. PubMed ID: 5273365
[No Abstract] [Full Text] [Related]
18. The role of androgens in the treatment of hematologic disorders.
Ammus SS
Adv Intern Med; 1989; 34():191-208. PubMed ID: 2644756
[No Abstract] [Full Text] [Related]
19. [Ineffective erythropoiesis and fetal hemoglobin (author's transl)].
Mitsutani S
Rinsho Ketsueki; 1977 Nov; 18(11):1291-302. PubMed ID: 340725
[No Abstract] [Full Text] [Related]
20. [Osteonecrosis and corticotherapy in a hematology department].
Laurens A; Pattin S; Dumouchel P; Charron D; Mathieu M; Martoia R
Ann Med Interne (Paris); 1977 Apr; 128(4):369-74. PubMed ID: 268158
[No Abstract] [Full Text] [Related]
[Next] [New Search]
